Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.70 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.70 |
| ▸ | HTT | P42858 | 1/20 | 0.70 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.53 |
| ▸ | TPMT | P51580 | 2/20 | 0.53 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.53 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31520156 | 1.00 | TSHR (0.70) | TSHRAPOBEC3AHTTAPOBEC3GSMN1; SMN2 | |
| SCHEMBL3349066 | 0.89 | TPMT (0.59) | TSHRAPOBEC3AHTTAPOBEC3GHPGD | |
| Methyl Syringate SCHEMBL211747 | 0.87 | MEN1 (0.61) | TSHRSMN1; SMN2TPMTMAPTALDH1A1 | |
| SCHEMBL28097333 | 0.85 | TSHR (0.64) | TSHRAPOBEC3AHTTAPOBEC3GSMN1; SMN2 | |
| SCHEMBL10205503 | 0.84 | SMN1; SMN2 (0.53) | TSHRAPOBEC3AHTTAPOBEC3GSMN1; SMN2 | |
| SCHEMBL1134614 | 0.84 | TSHR (0.72) | TSHRAPOBEC3AHTTAPOBEC3GSMN1; SMN2 | |
| SCHEMBL30740894 | 0.84 | HTT (0.72) | TSHRAPOBEC3AHTTAPOBEC3GSMN1; SMN2 | |
| SCHEMBL1204414 | 0.84 | HTT (0.72) | TSHRAPOBEC3AHTTAPOBEC3GSMN1; SMN2 | |
| SCHEMBL985701 | 0.82 | TSHR (0.70) | TSHRAPOBEC3AHTTAPOBEC3GSMN1; SMN2 | |
| SCHEMBL20604724 | 0.82 | PTPN1 (0.62) | TSHRAPOBEC3AHTTAPOBEC3GLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035341-A1 | FTO INHIBITORS | RPXDS CO LTD (CN) | 2026-02-05 | — | — | US | disclosed |
| EP-4561975-A1 | FTO INHIBITORS | RPXDS Co., Ltd (CN) | 2025-06-04 | — | — | EP | disclosed |
| WO-2024022491-A1 | FTO INHIBITORS | RPXDS CO., LTD (CN) | 2024-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035341-A1 | FTO INHIBITORS | FTO, LDLR, GPR119 | TSHR 416/4885APOBEC3A 3334/4885HTT 213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.